Savara (SVRA) News Today

$4.24
-0.45 (-9.59%)
(As of 04/24/2024 ET)
SourceHeadline
marketbeat.com logoSavara (NASDAQ:SVRA) Trading Down 6.6%
marketbeat.com - April 24 at 6:51 PM
marketbeat.com logoSavara Inc (NASDAQ:SVRA) Shares Acquired by Jennison Associates LLC
marketbeat.com - April 24 at 7:27 AM
MarketBeat logoJMP Securities Reiterates "Market Outperform" Rating for Savara (NASDAQ:SVRA)
americanbankingnews.com - April 20 at 1:54 AM
seekingalpha.com logoFYBR, BCRX and SABR are among after hour movers
seekingalpha.com - April 20 at 1:53 AM
marketbeat.com logoSavara's (SVRA) Market Outperform Rating Reiterated at JMP Securities
marketbeat.com - April 18 at 2:21 PM
marketbeat.com logoSavara (NASDAQ:SVRA) Trading Down 3.9%
marketbeat.com - April 17 at 12:20 PM
marketbeat.com logoSavara (NASDAQ:SVRA) Sees Large Volume Increase
marketbeat.com - April 15 at 1:54 PM
marketbeat.com logoVanguard Group Inc. Buys 789,249 Shares of Savara Inc (NASDAQ:SVRA)
marketbeat.com - April 14 at 4:16 AM
marketbeat.com logoSavara (NASDAQ:SVRA) Shares Up 3.6%
marketbeat.com - April 11 at 1:47 PM
markets.businessinsider.com logoOptimistic Buy Rating for Savara Based on Molgramostim’s Market Potential and Study Outcomes
markets.businessinsider.com - April 11 at 8:38 AM
marketbeat.com logoSavara (NASDAQ:SVRA) Trading Up 2.6%
marketbeat.com - April 4 at 12:45 AM
businesswire.com logoSavara Announces New Employment Inducement Grant
businesswire.com - March 22 at 4:05 PM
msn.com logoSavara Inc. Reports Increased Expenses, Anticipates Positive Data from IMPALA-2 Trial
msn.com - March 13 at 1:33 PM
marketbeat.com logoPolar Capital Holdings Plc Makes New Investment in Savara Inc (NASDAQ:SVRA)
marketbeat.com - March 13 at 7:54 AM
msn.com logoFDA lifts partial hold on Nurix Phase 1 study for NX-2127
msn.com - March 11 at 6:57 PM
markets.businessinsider.com logoBuy Rating Affirmed: Anticipating IMPALA-2 Trial Success and aPAP Treatment Breakthrough with Molgramostim
markets.businessinsider.com - March 11 at 1:57 PM
marketbeat.com logoSavara (NASDAQ:SVRA) Shares Down 5.5%
marketbeat.com - March 11 at 1:22 PM
finance.yahoo.com logoSVRA Jul 2024 7.500 call
finance.yahoo.com - March 10 at 9:20 AM
markets.businessinsider.com logoOptimistic Buy Rating for Savara on Molgramostim’s Market Potential and Strong Financials
markets.businessinsider.com - March 8 at 9:43 AM
msn.com logoSVRA Stock Earnings: Savara Beats EPS for Q4 2023
msn.com - March 7 at 11:08 PM
finance.yahoo.com logoSavara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
finance.yahoo.com - March 7 at 6:08 PM
usatoday.com logoBest penny stocks of March 2024
usatoday.com - March 6 at 4:44 PM
finance.yahoo.com logoSavara to Present at the Barclays 26th Annual Global Healthcare Conference
finance.yahoo.com - March 6 at 4:44 PM
marketbeat.com logoAdage Capital Partners GP L.L.C. Acquires 1,874,000 Shares of Savara Inc (NASDAQ:SVRA)
marketbeat.com - March 6 at 8:19 AM
marketbeat.com logoSavara (NASDAQ:SVRA) Reaches New 1-Year High on Analyst Upgrade
marketbeat.com - March 4 at 10:30 AM
marketbeat.com logoSavara (NASDAQ:SVRA) Given New $16.00 Price Target at Piper Sandler
marketbeat.com - March 4 at 8:24 AM
markets.businessinsider.com logoPiper Sandler Keeps Their Buy Rating on Savara (SVRA)
markets.businessinsider.com - March 1 at 2:54 PM
msn.com logoSavara (SVRA) Price Target Increased by 22.98% to 7.21
msn.com - February 24 at 7:32 AM
au.finance.yahoo.com logoSavara Inc. (YB4P.F)
au.finance.yahoo.com - February 22 at 7:52 AM
msn.com logoSee Leaked Details of Bensoul, Nviiri and Savara's Music Project
msn.com - February 21 at 12:05 AM
finance.yahoo.com logoSavara Inc. (NASDAQ:SVRA): Are Analysts Optimistic?
finance.yahoo.com - February 20 at 2:05 PM
marketbeat.com logoShort Interest in Savara Inc (NASDAQ:SVRA) Declines By 9.7%
marketbeat.com - February 16 at 6:20 PM
msn.com logoJMP starts Savara at buy, cites market potential for lung disease drug
msn.com - February 15 at 3:52 PM
marketbeat.com logoJMP Securities Initiates Coverage on Savara (NASDAQ:SVRA)
marketbeat.com - February 15 at 7:24 AM
benzinga.com logoSavara Stock (NASDAQ:SVRA) Dividends: History, Yield and Dates
benzinga.com - February 15 at 1:17 AM
marketbeat.com logoVivo Capital LLC Takes Position in Savara Inc (NASDAQ:SVRA)
marketbeat.com - February 6 at 1:40 PM
msn.com logoSavara Inc. to Participate in Prominent Healthcare Conferences, Casting Spotlight on Future Plans
msn.com - February 6 at 1:06 AM
marketbeat.com logoSavara (NASDAQ:SVRA) Sets New 1-Year High at $5.29
marketbeat.com - January 30 at 11:19 AM
marketbeat.com logoJennison Associates LLC Acquires 1,192,730 Shares of Savara Inc (NASDAQ:SVRA)
marketbeat.com - January 19 at 6:14 AM
marketbeat.com logoShort Interest in Savara Inc (NASDAQ:SVRA) Increases By 22.4%
marketbeat.com - January 13 at 8:53 PM
finance.yahoo.com logoInsider Sell: CEO Matthew Pauls Disposes of 84,000 Shares of Savara Inc (SVRA)
finance.yahoo.com - December 30 at 10:10 AM
marketbeat.com logoSavara Inc (NASDAQ:SVRA) CFO David L. Lowrance Sells 10,000 Shares
marketbeat.com - December 29 at 6:40 PM
msn.com logoSavara launches aPAP ClearPath blood test for rare lung disease
msn.com - December 22 at 2:24 PM
finance.yahoo.com logoSavara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
finance.yahoo.com - December 21 at 1:07 PM
msn.com logoSavara added to Nasdaq Biotechnology Index
msn.com - December 20 at 10:22 AM
finance.yahoo.com logoSavara Added to the NASDAQ Biotechnology Index
finance.yahoo.com - December 20 at 10:22 AM
marketbeat.com logoSavara Inc (NASDAQ:SVRA) Short Interest Update
marketbeat.com - December 14 at 9:37 PM
marketbeat.com logoCaxton Corp Has $16.03 Million Holdings in Savara Inc (NASDAQ:SVRA)
marketbeat.com - December 10 at 11:35 AM
finance.yahoo.com logoSavara Inc. (NASDAQ:SVRA) most popular amongst private equity firms who own 41% of the shares, institutions hold 31%
finance.yahoo.com - December 1 at 3:06 PM
morningstar.com logoSavara Inc SVRA
morningstar.com - November 26 at 9:14 AM
Get Savara News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVRA and its competitors with MarketBeat's FREE daily newsletter.

Will this $2 AI stock double overnight? (Ad)

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>

SVRA Media Mentions By Week

SVRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SVRA
News Sentiment

0.68

0.44

Average
Medical
News Sentiment

SVRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SVRA Articles
This Week

6

1

SVRA Articles
Average Week

Get Savara News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:SVRA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners